secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K
Filed at:   2023-12-05T23:59:59+00:00
Accession:  0001213900-23-093122
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma reduces authorized shares to 100M, adjourns annual meeting for Nevada reincorporation
--------------------------------------------------------------------------------

- Shareholders approved decrease of authorized common stock from 500M to 100M; Certificate of Amendment filed Dec 4, 2023.
- Annual meeting adjourned solely for Proposal 3 (reincorporation from Delaware to Nevada); other proposals approved.
- Reconvened meeting set for Dec 11, 2023 at 11am ET in Sarasota, FL; record date Oct 12, 2023 unchanged.
- Proxies already submitted will be voted on reincorporation; stockholders need not vote again.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023093122/0001213900-23-093122-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023093122/ea189550-8k_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-093122

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer